Lineage Cell Therapeutics
LCTX
#8221
Rank
โ‚น13.58 B
Marketcap
โ‚น71.92
Share price
1.22%
Change (1 day)
-32.48%
Change (1 year)

EPS for Lineage Cell Therapeutics (LCTX)

EPS in 2023 (TTM): -โ‚น10.67

According to Lineage Cell Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น10.93. In 2022 the company made an earnings per share (EPS) of -โ‚น12.61 an increase over its 2021 EPS that were of -โ‚น21.86.

EPS history for Lineage Cell Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น10.67-15.42%
2022-โ‚น12.61-42.31%
2021-โ‚น21.8685.71%
2020-โ‚น11.77250%
2019-โ‚น3.36-88.57%
2018-โ‚น29.43105.88%
2017-โ‚น14.29-153.13%
2016โ‚น26.91-154.24%
2015-โ‚น49.615.36%
2014-โ‚น47.09-30.86%
2013-โ‚น68.1188.37%
2012-โ‚น36.1519.44%
2011-โ‚น30.2733.33%
2010-โ‚น22.7068.75%
2009-โ‚น13.45-5.88%
2008-โ‚น14.29183.33%
2007-โ‚น5.04-25%
2006-โ‚น6.73-27.27%
2005-โ‚น9.25-38.89%
2004-โ‚น15.1338.46%
2003-โ‚น10.93-43.48%
2002-โ‚น19.34-26.63%
2001-โ‚น26.36-28.75%
2000-โ‚น37.00-13.73%
1999-โ‚น42.88
1997-โ‚น27.753.13%
1996-โ‚น26.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น183.30 1,576.92%๐Ÿ‡บ๐Ÿ‡ธ USA